- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Developing inhaled protein therapeutics for lung diseases ; volume:1 ; number:1 ; day:30 ; month:10 ; year:2020 ; pages:1-14 ; date:12.2020
Molecular biomedicine ; 1, Heft 1 (30.10.2020), 1-14, 12.2020
- Urheber
-
Matthews, Abigail A.
Ee, Pui Lai Rachel
Ge, Ruowen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-020-00014-z
- URN
-
urn:nbn:de:101:1-2020121207382742785759
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Matthews, Abigail A.
- Ee, Pui Lai Rachel
- Ge, Ruowen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glycans in diseases and therapeutics
Developing novel specific therapeutics targeting adipocytes
Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases
Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
Highway to Success—Developing Advanced Polymer Therapeutics
Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases
Developing the Lung Graph-Based Machine Learning Model for Identification of Fibrotic Interstitial Lung Diseases
Signaling pathways of chronic kidney diseases, implications for therapeutics
Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats
Mass spectrometry detection of inhaled drug in distal fibrotic lung
Inhaled Pro‐Efferocytic Nanozymes Promote Resolution of Acute Lung Injury
Glycans in diseases and therapeutics
Developing novel specific therapeutics targeting adipocytes
Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases
Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
Highway to Success—Developing Advanced Polymer Therapeutics
Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases
Developing the Lung Graph-Based Machine Learning Model for Identification of Fibrotic Interstitial Lung Diseases
Signaling pathways of chronic kidney diseases, implications for therapeutics
Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats
Mass spectrometry detection of inhaled drug in distal fibrotic lung
Inhaled Pro‐Efferocytic Nanozymes Promote Resolution of Acute Lung Injury
Glycans in diseases and therapeutics
Developing novel specific therapeutics targeting adipocytes
Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases
Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
Highway to Success—Developing Advanced Polymer Therapeutics
Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases
Developing the Lung Graph-Based Machine Learning Model for Identification of Fibrotic Interstitial Lung Diseases
Signaling pathways of chronic kidney diseases, implications for therapeutics
Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats
Mass spectrometry detection of inhaled drug in distal fibrotic lung